Fast induces Fas/Apo1-mediated apoptosis in human embryonic kidney 293 cells routinely used to generate E1-deleted adenoviral vectors

被引:32
作者
Larregina, AT
Morelli, AE
Dewey, RA
Castro, MG
Fontana, A
Lowenstein, PR
机构
[1] Univ Manchester, Dept Med, Mol Med Unit, Manchester M13 9PT, Lancs, England
[2] Univ Zurich Hosp, Dept Internal Med, Clin Immunol Sect, Zurich, Switzerland
基金
英国惠康基金;
关键词
293; cells; adenoviral vectors; FasL; Fas/Apo-1; apoptosis; immune privilege;
D O I
10.1038/sj.gt.3300615
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human embryonic kidney 293 cells contain the E1 region of adenovirus type 5, and thus sustain, through transcomplementation, the production of recombinant E1-deleted adenovirus vectors, During attempts to produce recombinant adenovirus expressing the apoptosis-inducing molecule Fas ligand (FasL) under the control of a very strong truncated major immediate-early human cytomegalovirus (MEhCMV) promoter, we discovered that 293 cells were nor surviving the initial cotransfection with a shuttle plasmid encoding the mouse FasL; and pJM17 a plasmid containing the genome of adenovirus type 5 with deletions in the E1-E3 regions, in an unpackagable form. Investigation of the reason for massive cell death after cotransfection led us to determine that 293 cells express the FasL receptor Fas-Apo1 (CD95), and respond with apoptosis to the cross-linking of Fas-Apo1 with either IgM monoclonal antibodies or FasL. Therefore, we decided to generate adenoviral vectors expressing FasL under the control of tissue-specific and/or -inducible promoter elements. Our findings can explain difficulties several groups have had in generating recombinant adenoviral vectors expressing FasL using 293 cells, as well as the lower titres reported.
引用
收藏
页码:563 / 568
页数:6
相关论文
共 30 条
[21]   LOCAL FAS/APO-1 (CD95) LIGAND-MEDIATED TUMOR-CELL KILLING IN-VIVO [J].
RENSINGEHL, A ;
FREI, K ;
FLURY, R ;
MATIBA, B ;
MARIANI, SM ;
WELLER, M ;
AEBISCHER, P ;
KRAMMER, PH ;
FONTANA, A .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (08) :2253-2258
[22]   Testis-derived Sertoli cells survive and provide localized immunoprotection for xenografts in rat brain [J].
Sanberg, PR ;
Borlongan, CV ;
Saporta, S ;
Cameron, DF .
NATURE BIOTECHNOLOGY, 1996, 14 (13) :1692-1695
[23]   Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells - A mechanism of immune evasion? [J].
Strand, S ;
Hofmann, WJ ;
Hug, H ;
Muller, M ;
Otto, G ;
Strand, D ;
Mariani, SM ;
Stremmel, W ;
Krammer, PH ;
Galle, PR .
NATURE MEDICINE, 1996, 2 (12) :1361-1366
[24]   MOLECULAR-CLONING AND EXPRESSION OF THE FAS LIGAND, A NOVEL MEMBER OF THE TUMOR-NECROSIS-FACTOR FAMILY [J].
SUDA, T ;
TAKAHASHI, T ;
GOLSTEIN, P ;
NAGATA, S .
CELL, 1993, 75 (06) :1169-1178
[25]   HUMAN FAS LIGAND - GENE STRUCTURE, CHROMOSOMAL LOCATION AND SPECIES-SPECIFICITY [J].
TAKAHASHI, T ;
TANAKA, M ;
INAZAWA, J ;
ABE, T ;
SUDA, T ;
NAGATA, S .
INTERNATIONAL IMMUNOLOGY, 1994, 6 (10) :1567-1574
[26]   Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors [J].
Tripathy, SK ;
Black, HB ;
Goldwasser, E ;
Leiden, JM .
NATURE MEDICINE, 1996, 2 (05) :545-550
[27]   Role of Fas-mediated cell death in the regulation of immune responses [J].
vanParijs, L ;
Abbas, AK .
CURRENT OPINION IN IMMUNOLOGY, 1996, 8 (03) :355-361
[28]   ANTI-FAS APO-1 ANTIBODY-MEDIATED APOPTOSIS OF CULTURED HUMAN GLIOMA-CELLS - INDUCTION AND MODULATION OF SENSITIVITY BY CYTOKINES [J].
WELLER, M ;
FREI, K ;
GROSCURTH, P ;
KRAMMER, PH ;
YONEKAWA, Y ;
FONTANA, A .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (03) :954-964
[29]  
WILKINSON GW, 1991, ADV GENE TECHNOLOGY, P287
[30]   Amelioration of collagen-induced arthritis by CD95 (Apo-1/Fas)-ligand gene transfer [J].
Zhang, HD ;
Yang, YP ;
Horton, JL ;
Samoilova, EB ;
Judge, TA ;
Turka, LA ;
Wilson, JM ;
Chen, YH .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (08) :1951-1957